Retroviral Insertion Site Methodology Study

Status Withdrawn

Clinical Trial Summary

Adenosine deaminase (ADA) is an enzyme involved in the development and functioning of the immune system. Deficiency of ADA results in severe combined immunodeficiency (SCID), a fatal inherited immune disorder. Strimvelis is a gene therapy that aims to insert ADA function into blood cells and halt or reverse the conditions caused by decreased ADA enzyme levels, such as impaired immune function. It is important to consider long term follow-up of patients who have received Strimvelis, including evaluation of the risk of insertion near certain genes that may lead to unexpected activation of those genes (oncogenesis). The objective of this study is to evaluate the use of a new technique to identify where Strimvelis has become inserted in the genetic sequence, and potential implications for patient care. This new technique is known as sonication linker mediated polymerase chain reaction (SLiM-PCR) for retroviral insertion site (RIS) analysis. The study will recruit at least 15 pediatric or adult patients with ADA-SCID who have been treated with Strimvelis, either in previous clinical trials or as a registered product. Recruitment for the study may remain open for up to 2 years even if 15 subjects are recruited sooner. Study participation will last for up to 5 years. A total of 5 blood samples will be collected from each subject at approximately annual intervals.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Immune System Diseases

Clinical Trial Details

NCT number	NCT03311074
Study type	Interventional
Source	Fondazione Telethon
Contact
Status	Withdrawn
Phase	Phase 4
Start date	June 25, 2020
Completion date	July 9, 2020

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT03663933` - Allogeneic Hematopoietic Cell Transplantation for Disorders of T-cell Proliferation and/or Dysregulation	Phase 2
Completed	`NCT03563066` - Effect of Benralizumab in Atopic Dermatitis	Phase 2
Recruiting	`NCT04339777` - Allogeneic Hematopoietic Stem Cell Transplant for Patients With Inborn Errors of Immunity	Phase 2
Not yet recruiting	`NCT05969821` - Clonal Hematopoiesis of Immunological Significance
Completed	`NCT02916888` - A Study Comparing the Quality of Life of Patients in the Treatment of Eczema by Pediatric Generalists and Specialists	N/A
Completed	`NCT02527187` - Determination of the Sensitivity and Specificity of Prick Test Betula Verrucosa	Phase 2
Completed	`NCT01441076` - Anakinra for Behcet s Disease	Phase 1/Phase 2
Completed	`NCT01472263` - Use of Pentoxifylline in Human T-lymphotropic Virus Type-1 (HTLV-1) Diseases	Phase 3
Completed	`NCT03720470` - Study Evaluating Efficacy and Safety of PF-04965842 and Dupilumab in Adult Subjects With Moderate to Severe Atopic Dermatitis on Background Topical Therapy	Phase 3
Suspended	`NCT04642066` - Cold Water Immersion and Atherosclerosis, Inflammation, Fat Accumulation and Lipid Profile Parameters	N/A
Completed	`NCT02294552` - Post-transplantation Cyclophosphamide as GVHD Prophylaxis After HSCT	Phase 2
Completed	`NCT01727973` - Efficacy of Subantimicrobial Dose Doxycycline for Moderate to Severe and Active Graves' Orbitopathy	Phase 1/Phase 2
Completed	`NCT04103099` - Impact of HLNatural Immune Supplement on Colds	N/A
Recruiting	`NCT03344094` - Mechanism of Action of Ocrelizumab in Multiple Sclerosis	N/A
Active, not recruiting	`NCT05445284` - Group Education Trial to Improve Transition for Parents of Adolescents With T1D	N/A
Recruiting	`NCT06104111` - Epigenetic Memory of Vitamin D Supplementation	Phase 1
Not yet recruiting	`NCT05616117` - Next-generation Effects of Vitamin D Supplementation in Pregnancy
Completed	`NCT01510626` - Omalizumab With Oral Food Immunotherapy With Food Allergies Open Label Safety Study in a Single Center	Phase 1
Completed	`NCT01490177` - Single Center Food Allergy Oral Immunotherapy Study	Phase 1
Completed	`NCT03922087` - No-worry Baby Project